3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis

by 3PBIOVIAN

​3P Biopharmaceuticals and the Swedish company, Toleranzia AB, have successfully accomplished 1000 L full-scale GMP manufacturing of TOL2 drug substance destinated to be used in clinical study.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Some regions of the human genome conside...

by Universitat de Barcelona

Many repetitive regions of the genome have been considered “junk DNA...

Photos Stream